Histopathology and growth rate of interval breast carcinoma: Characterization of different subgroups

Cancer

Volumn 78, Issue 6, 1996, Pages 1220-1228

  Brekelmans, Cecile T ^a,c   Van Gorp, Joost M ^b   Peeters, Petra H ^a   Collette, Hubertine J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Academic Hospital   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

breast cancer screening; interval cancer; mammography; prognostic factors; survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BREAST; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MITOSIS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 0029786649     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960915)78:6<1220::AID-CNCR8>3.0.CO;2-D     Document Type: Article

References (37)

1. Brekelmans CTM, Peeters PHM, Faber JAJ, Deurenberg JJM, Collette HJA. The epidemiologic profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 1994,30:223-32.
2. Brekelmans CTM, Peeters PHM, Deurenberg JJM, Collette HJA. Survival of interval breast cancer diagnosed in women participating in the DOM screening programme. Eur J Cancer 1995;31(A):1830-35.
3. Shapiro S, Venet W, Strax PH, Venet L, Roeser R. Ten-to-fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.
4. Holmberg LH, Adami HO, Tabár L, Bergström R. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986;ii:27-30.
5. Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 1989; 59:929-32.
6. Holland R, Mravunac M, Hendriks JHCL, Bekker B. Pathologic and radiologic analysis of sixty-four cases. Cancer 1982;49:2527-33.
7. Waard F de, Collette HJA, Rombach JJ, Baanders-van Halewijn EA, Honing C. The DOM project for the early detection of breast cancer, Utrecht, the Netherlands. J Chron Dis 1984;37:1-44.
8. Bloom HJG, Richardson WW. Htstological grading and prognosis in breast carcinoma. Br J Cancer 1957;11:359-77.
9. Philippe E, Gal Y le. Growth of seventy-eight recurrent mammary cancers. Quantative study. Cancer 1968;21:461-67.
10. Kuroishi T, Tominaga S, Morimoto T, Tashiro H, Itoh S, Wanatabe H, et al. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res 1990;81:454-62.
11. Peer PGM, van Dijck JAAM, Hendriks JHCL, Holland R, Verbeek ALM. Age-dependent growth rate of primary breast cancer. Cancer 1993;71:3547-51.
12. Egret reference manual, first draft, 1985-1990.
13. Holland R, Hendriks JHCL, Mravunac M. Mammographically occult breast cancer. A pathologic and radiologic study. Cancer 1983;52:1810-19.
14. Heuser LS, Spratt JS, Kuhns JG, Chang AFC, Polk H, Buchanan JB. The association of pathologic and mammographic characteristics of primary human breast cancers with "slow" and "fast" growth rates and with axillary lymph node metastases. Cancer 1984;53:96-8.
15. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992;84:781-5.
16. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992; 184:613-7.
17. Ikeda DM, Andersson I, Wattsgard C, Janzon L, Linell F. Interval carcinomas in the Malmö mammographic screening trial: radiographic appearance and prognostic considerations. AJR Am J Roentgenol 1992;159:287-94.
18. Duffy SW, Tabár L, Fagerberg G, Gad A, Gröntoft O, South MC, et al. Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer 1991;64:1133-8.
19. Holmberg L, Ponten J, Adami H-O. The biology and natural history of breast cancer from the screening perspective. World J Surg 1989;13:25-30.
20. Mitze M, Meyer F, Goepel E, Kleinkauf-Houcken A, Jonat W. Besonderheiten in Klinik und Verlauf beim invasiven lobularen Mammakarzinom. Geburtshilfe-Frauenheilkd 1991;51:973-9.
21. Hilleren DJ, Andersson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology 1991;178:149-54.
22. Osteen RT. Selection of patients for breast conserving surgery. Cancer 1994;74:366-71.
23. Spratt JS, Heuser L, Greg Kuhns G, Reiman HM, Buchanan JB, Polk HC, et al. Association between the actual doubling times of primary breast cancer with histopathologic characteristics and Wolfe's parenchymal mammographic patterns. Cancer 1981;47:2265-8.
24. Rosen von A, Erhardt K, Hellström L, Somell A, Auer G. Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treat 1985;6:221-7.
25. Arnerlöv C, Emdin SO, Lundgren B, Roos G, Söderström J, Bjersing L, et al. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Cancer 1992;70:1928-34.
26. Moskowitz M. Breast cancer: age specific growth rates and screening strategies. Radiology 1986;161:37-41.
27. Spratt JS, Greenberg RA, Heuser LS. Geometry, growth rates and duration of cancer and carcinoma in situ of the breast before detection by screening. Cancer Res 1986;46:970-4.
28. Eideken S. Mammography and palpable cancer of the breast. Cancer 1988;61:263-5.
29. Spratt JA, Fournier D, Spratt JS, Weber EE. Mammographic assessment of human breast cancer growth and duration. Cancer 1993;71:2020-6.
30. Clayton F. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas: mitotic count is the best single predictor. Cancer 1991;68:1309-17.
31. Stierer M, Rosen H, Weber R. Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer. Breast Cancer Res Treat 1991;20:109-16.
32. Schumacher M, Schmoor C, Sauerbrei W, Schauer A, Ummenhofer L, Gatzemeier W, et al. The prognostic effect of histological tumor grade in node-negative breast cancer patients. Breast Cancer Res Treat 1993;25:235-45.
33. Anderson EDC, Muir BB, Walsh JS, Kirkpatrick AE. The efficacy of double reading mammograms in breast screening. Clin Radiol 1994;49:248-51.
34. Van Dijck JAAM, Verbeek ALM, Hendriks JHCL, Holland R. One-view versus two-view mammography in baseline screening for breast cancer: a review. Br J Radiol 1992; 65:971-6.
35. Von Rosen A, Frisell J, Nilsson R, Wiege M, Auer G. Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm mammography screening project. Acta Oncol 1992;31:399-402.
36. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 1995;310:224-6.
37. Burhenne HJ, Burhenne LW, Goldberg F, Hislop TG, Worth A, Rebbeck PM, et al. Interval breast cancers in the screening mammography program of British Columbia: analysis and classification. AJR Am J Roentgenol 1994;162:1067-71.